Clinical Trials in Denver

Showing 7881-7900 of 18,161 trials

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

NCT01728259

This phase I trial studies the side effects and best dose of pomalidomide and bortezomib when given together with dexamethasone in treating patients with amyloid light-chain amyloidosis or light chain deposition disease. Biological therapies, such as pomalidomide, may stimulate the immune system in different ways and stop abnormal cells from growing. Bortezomib may stop the growth of abnormal cells by blocking some of the enzymes needed for cell growth. Giving pomalidomide and bortezomib together with dexamethasone may be an effective treatment for amyloid light-chain amyloidosis or light chain deposition disease

Light Chain Deposition DiseasePrimary Systemic Amyloidosis

Barbara Ann Karmanos Cancer Institute18 participantsStarted Mar 2013

Denver, Colorado, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +2 more locations

WITHDRAWNNA< 1 mile

Subject Evaluation of a 1064nm Diode Laser/RF

NCT04090853

Open-label, baseline-controlled, multi-center study evaluating a 1064 nm diode laser, pulsed electromagnetic fields and vacuum assisted radio frequency for non-invasive fat reduction of the abdomen and flanks.

Subcutaneous Fat Disorder

Venus ConceptStarted Oct 2019

Denver, Colorado, United States • Foxborough, Massachusetts, United States • Woodmere, New York, United States

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Subject Evaluation of a 1064nm Diode Laser/RF

Find Trials by Condition in Denver

Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension

Point of Care Ultrasound Measurements of Perioperative Edema in Infants With Congenital Heart Disease

Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids

Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

P3 Long Term Safety Study of Once Daily SB204 in Acne

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Promoting The Self-Regulation Of Energy Intake

Study of ASN003 in Subjects With Advanced Solid Tumors

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

RISE Adult Medication Study

Study Evaluating the Efficacy and Safety of Yoni.Fit in Women With Stress Urinary Incontinence